Study of the effect of MigraineCut drug on migraine headaches

Not Applicable

Recruiting

• Conditions: Migraine.; Migraine

• Registration Number: IRCT20170705034915N3
• Lead Sponsor: MIMDaroo Pharmaceutical Co.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 492

Inclusion Criteria

Patient with migraine after being diagnosed by a neurologist.
Male or female patient has a migraine attack at least one month per year.
Patient aged between 16 and 60 years who has the opportunity to complete the diary form and communicate effectively with the counselor.
Patient that doesn't have susceptibility to herbal medicines.

Exclusion Criteria

Patient with probable migraine headaches
Patients with medication overused headaches
Patients with complex headaches
Patients who provide incomplete data and information to the counselor.
Patients who do not wish to start or continue treatment with knowledge of the conditions of the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Headeches frequency. Timepoint: Counting the number of headaches from the beginning of the study (before the intervention), 30, 60, 90, and 120 days after the start of the MigraineCut. Method of measurement: headache diary form.;Headache intensity. Timepoint: Record the intensity of each migraine attack every month for up to 4 months during the study. Method of measurement: Headache diray form.;Headache duration. Timepoint: Calculate the duration of headaches before the intervention, and during 30, 60, 90, and 120 days from the onset of intervention with cutaneous migraine. Method of measurement: Headache diray form.

Secondary Outcome Measures

Name	Time	Method
Changes in the clinical symptoms of migraineurs. Timepoint: Clinical symptoms of patients, such as sensitivity to light and sound before intervention, and 30, 60, 90, and 120 days after intervention are investigated. Method of measurement: Headache diary form and expert visit.